Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Congenital Anomalies Initiative

Overview

The mission of the Congenital Anomalies Initiative (formerly the Birth Defects Initiative) is to capitalize on genomic and other biomedical discoveries to further understanding of the mechanisms responsible for congenital anomalies, which, according to the Centers for Disease Control and Prevention, affect about 3% of all live births in the United States each year.

The goal is the development of new, innovative, and valuable strategies for the molecular diagnosis, treatment, and prevention of human structural congenital anomalies. It is led by the Developmental Biology and Congenital Anomalies Branch (DBCAB), formerly known as the Developmental Biology and Structural Variation Branch.

Through the initiative, DBCAB supports basic scientists and clinicians whose research projects span basic, translational, and clinical approaches to understanding the developmental biology and genetics of structural congenital anomalies.

More Information

top of page BACK TO TOP